Jason Pitofsky, SVP Controller at REGENERON PHARMACEUTICALS, INC. (REGN), sold 2,036 shares at $776.43 ($1.6M) on 2026-02-09, disclosed to the SEC on 2026-02-11.
Scheduled sale ($1.6M) by SVP Controller under a pre-arranged 10b5-1 plan. Pre-set trade — not a discretionary signal on the stock.
Something here stands out, but not much.
| # | Price | Shares | Value | % of Total |
|---|---|---|---|---|
| 1 | $775.95 | 20 | $16K | 1.0% |
| 2 | $776.43 | 521 | $405K | 25.5% |
| 3 | $777.51 | 391 | $304K | 19.2% |
| 4 | $778.35 | 563 | $438K | 27.6% |
| 5 | $779.56 | 205 | $160K | 10.1% |
| 6 | $780.06 | 75 |
| $59K |
| 3.7% |
| 7 | $781.37 | 26 | $20K | 1.3% |
| 8 | $782.67 | 37 | $29K | 1.8% |
| 9 | $783.23 | 144 | $113K | 7.1% |
| 10 | $784.66 | 1 | $785 | 0.0% |
| 11 | $785.72 | 53 | $42K | 2.6% |
| Total | $778.52 avg | 2,036 | $1.6M | 100% |
| Filing → |